Skip to main content
SpringerPlus

Table 3 Cardiovascular and respiratory complications

From: High thoracic anesthesia offers no major benefit over general anesthesia in on-pump cardiac surgery patients: a retrospective study

 

GA, n = 141

TEA, n = 147

P value

Myocardial infarction

1 (0.7 %)

0

0.490

Low cardiac output

5 (3.5 %)

9 (6.1 %)

0.309

Ionotropes

28 (19.9 %)

33 (22.4 %)

0.591

IABP

3 (2.1 %)

7 (4.8 %)

0.336

Atrial fibrillation

37 (26.2 %)

44 (29.9 %)

0.486

NE support

92 (65.2 %)

100 (68 %)

0.882

NE > 0.1 µg/kg/min

29 (20.6 %)

31 (21.1 %)

0.806

NE total dose (µg/kg)

211 ± 807

123 ± 289

0.260

NE support duration (h)

28 ± 36

21 ± 29

0.114

ICU fluid balance (mL)

3890 ± 1936

3518 ± 2405

0.124

Lung atelectasis

6 (4.3 %)

8 (5.4 %)

0.640

Pneumonia

1 (0.7 %)

4 (2.7 %)

0.371

Time to extubation (h)

6.9 ± 8.8

6.0 ± 10.0

0.002

Reintubation

4 (2.8 %)

2 (1.4 %)

0.428

  1. IABP intra-aortic balloon pump, NE norepinephrine, TIA transitory ischemic attack, ICU intensive care unit
  2. Italic value indicates significance value of P < 0.05
Back to article page